In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 153 for your search:
Drug:  thalidomide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: TaCyDexVMP7, NCT00652041

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: UARK 2003-26, NCT00090493

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: Other
Protocol IDs: 01-002-0601, NCT00205751

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 000080, 00-C-0080, NCI-00-C-0080, NCI-T99-0053, T99-0053, NCT00020085, NCT00004635

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-2898, NCT00005966, E2898

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: CKTO-2001-02, HOVON-50MM, EU-20133, HOVON-CKVO-2001-02, NCT00028886

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-2012-02461, RTOG-BR-0118, CDR0000069268, RTOG-DEV-1006, U10CA021661, NCT00033254

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000069274, U10CA021115, E-E1A00, E1A00, NCT00033332

9.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-02475, CDR0000069441, GOG-0198, U10CA027469, NCT00041080

10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI, Other
Protocol IDs: MY10, CAN-NCIC-MY10, CAN-NCIC-JMY10, ECOG-NCIC-JMY10, CELGENE-CAN-NCIC-MY10, CDR0000258158, NCIC-MY.10, NCT00049673

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000302440, LLCG-STUDY-12, EU-20207, ISRCTN16174527, NCT00061919

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: THAL-MM-003, NCT00057564

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR004579, DO04-23-006, NCT00097981

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UARK 2005-01, NCT00111748

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 2004.00, NCI-2009-01543, FHCRC-2004.00, 6004, MEDIMMUNE-FHCRC-2004.00, NCT00217438

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: NMSG #12, NFR 90000288, NCT00218855

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 60
Sponsor: Other
Protocol IDs: MM01, NCT00207805

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EudraCT: 2005-001628-35, EBMT-CLWP: 42206611, NCT00256776

19.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000530050, P30CA015083, MC0289, 421-03, MAYO-MC0289, MAYO-IRB-421-03, NCT00432458

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 66 and over
Sponsor: Other
Protocol IDs: 2005-001111-21, NCT00443235

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: THA PH INT 2005 CL001, NCT00452569

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: 2005-001110-41, NCT00461747

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: C05009, NCT00507416

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 74
Sponsor: Other
Protocol IDs: UARK 2006-66, NCT00572169

25.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00522, CDR0000583984, ECOG-E1A06, E1A06, U10CA021115, U10CA180820, NCT00602641
1     
New Search